These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10094611)

  • 1. Binary quantitative structure-activity relationship (QSAR) analysis of estrogen receptor ligands.
    Gao H; Williams C; Labute P; Bajorath J
    J Chem Inf Comput Sci; 1999; 39(1):164-8. PubMed ID: 10094611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore fingerprinting. 1. Application to QSAR and focused library design.
    McGregor MJ; Muskal SM
    J Chem Inf Comput Sci; 1999; 39(3):569-74. PubMed ID: 10361729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico screening of estrogen-like chemicals based on different nonlinear classification models.
    Liu H; Papa E; Walker JD; Gramatica P
    J Mol Graph Model; 2007 Jul; 26(1):135-44. PubMed ID: 17293141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of quantitative structure-activity relationship methods for large-scale prediction of chemicals binding to the estrogen receptor.
    Tong W; Lowis DR; Perkins R; Chen Y; Welsh WJ; Goddette DW; Heritage TW; Sheehan DM
    J Chem Inf Comput Sci; 1998; 38(4):669-77. PubMed ID: 9722424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of BCUT metrics and genetic algorithm in binary QSAR analysis.
    Gao H
    J Chem Inf Comput Sci; 2001; 41(2):402-7. PubMed ID: 11277729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binary QSAR: a new method for the determination of quantitative structure activity relationships.
    Labute P
    Pac Symp Biocomput; 1999; ():444-55. PubMed ID: 10380218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of binary QSAR analysis by a GA-based variable selection method.
    Gao H; Lajiness MS; Van Drie J
    J Mol Graph Model; 2002 Jan; 20(4):259-68. PubMed ID: 11858634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative binding affinity does not predict biological response to xenoestrogens in rat endometrial adenocarcinoma cells.
    Strunck E; Stemmann N; Hopert A; Wünsche W; Frank K; Vollmer G
    J Steroid Biochem Mol Biol; 2000 Oct; 74(3):73-81. PubMed ID: 11086226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binary classification of a large collection of environmental chemicals from estrogen receptor assays by quantitative structure-activity relationship and machine learning methods.
    Zang Q; Rotroff DM; Judson RS
    J Chem Inf Model; 2013 Dec; 53(12):3244-61. PubMed ID: 24279462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activities and receptor affinities of some natural and synthetic oestrogens and their D-homo analogues.
    Lotz W
    Experientia; 1978 Oct; 34(10):1373-4. PubMed ID: 738432
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds.
    Waller CL
    J Chem Inf Comput Sci; 2004; 44(2):758-65. PubMed ID: 15032558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular determinants of tissue selectivity in estrogen receptor modulators.
    Grese TA; Sluka JP; Bryant HU; Cullinan GJ; Glasebrook AL; Jones CD; Matsumoto K; Palkowitz AD; Sato M; Termine JD; Winter MA; Yang NN; Dodge JA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14105-10. PubMed ID: 9391160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluation of the first synthetic estrogen, 1-keto-1,2,3, 4-tetrahydrophenanthrene, and bisphenol A, using both the ovariectomised rat model used in 1933 and additional assays.
    Ashby J; Odum J; Paton D; Lefevre PA; Beresford N; Sumpter JP
    Toxicol Lett; 2000 Jun; 115(3):231-8. PubMed ID: 10814893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of an average mammalian estrogen receptor-based QSAR model.
    Mekenya O; Kamenska V; Serafimova R; Poellinger L; Brouwer A; Walker J
    SAR QSAR Environ Res; 2002 Oct; 13(6):579-95. PubMed ID: 12479373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-like compounds for ischemic neuroprotection.
    Simpkins JW; Yang SH; Liu R; Perez E; Cai ZY; Covey DF; Green PS
    Stroke; 2004 Nov; 35(11 Suppl 1):2648-51. PubMed ID: 15472107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of OASIS QSAR Models Using ToxCast™ in Vitro Estrogen and Androgen Receptor Binding Data and Application in an Integrated Endocrine Screening Approach.
    Bhhatarai B; Wilson DM; Price PS; Marty S; Parks AK; Carney E
    Environ Health Perspect; 2016 Sep; 124(9):1453-61. PubMed ID: 27152837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of binary QSAR models derived from LUDI and MOE scoring functions for structure based virtual screening.
    Prathipati P; Saxena AK
    J Chem Inf Model; 2006; 46(1):39-51. PubMed ID: 16426038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative binding affinities of estrogen derivatives.
    Katzenellenbogen JA
    Cancer Treat Rep; 1978 Aug; 62(8):1243-9. PubMed ID: 688261
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure-activity relationship study of a diverse set of estrogen receptor ligands (I) using MultiCASE expert system.
    Klopman G; Chakravarti SK
    Chemosphere; 2003 May; 51(6):445-59. PubMed ID: 12615096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.
    Wiese TE; Polin LA; Palomino E; Brooks SC
    J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.